Introduction
============

Infection by *Helicobacter pylori (H. pylori)* is associated with gastritis, duodenal and gastric ulcer, gastric adeno-carcinoma and mucosa-associated lymphoid tissue lymphoma. In developing countries infection occurs predominantly in childhood and the infected individuals maintain *H. pylori* strains in their stomach for the decades ^\[[@B1]--[@B2]\]^ . Numerous studies have suggested presence of genetic difference between *H. pylori* strains isolated from various geographical areas ^\[[@B3]--[@B7]\]^ . However, some relatedness was observed between the *H. pylori* strains isolated in one geographical area ^\[[@B8]--[@B11]\]^ . Concerning pathogenicity-associated markers (*cagA* and *vacA*)*,* correlation was observed between *vacA* s1 genotype and *cagA* status of *H.* py*lori* and more severe gastroduodenal diseases. However, some discrepancies related to either the geography of strains, or generation of variants during infection, was observed ^\[[@B12]--[@B14]\]^ . The studies investigating genomic diversity among *H. pylori* strains have employed restriction-endonuclease patterns, ribotyping, sequencing of housekeeping genes, and PFGE ^\[[@B15]--[@B21]\]^ .

PFGE is a rapid method for characterization of individual strains of bacterial species and to demonstrate the clonal relation between the bacterial strains regardless of the year of isolation ^\[[@B22]\]^ . This method may also be the most suitable for a local epidemiological study of the molecular relatedness among *H. pylori* strains isolated from unrelated patients.

Previous studies on molecular relatedness of *H. pylori* isolated from the members of the family have shown the identical alleles found in some strains isolated from the children and parents, but not in the strains isolated from unrelated patients ^\[[@B23]\]^ .

The purpose of this study was to look for the degree of genomic diversity among *H. pylori* strains isolated from unrelated Iranian children, on the basis of *vacA* genotype, *cagA* status of the strains, and age, sex, as well as the pathological status of the patients.

Subjects and Methods
====================

Strains were isolated from 44 pediatric patients during the periods of 1997--1999 (group I), 2001--2003 (group II), 2005--2007 (group III), and 2007--2009 (group IV). The reason of this strain selection was to study the molecular relatedness of *H. pylori* strains isolated in this area from non related patients in avoiding their clonal relation. So the patients admitted to Children's Medical Center, Tehran for their persistent upper gastrointestinal problems during 1997--2009, were selected.

Local ethics committees approved the protocols under which the biopsies for histology and culture were obtained, and informed consent has been obtained. They were all in accordance with the Helsinki Declaration of 1975.

For isolation of primary *H. Pylori* strains, the antral biopsies have been processed according to the previously described protocol ^\[[@B24]\]^ . Briefly, the isolates were cultivated on campy-blood agar plates containing brucella agar base, 10% sheep blood, and antibiotics after enrichment in modified campy-thio medium (Merck, Germany). Following the initial growth in campy-blood agar plates, the pure cultures were produced from each isolate and identification was performed by Gram staining, positive urease, oxidase and catalase tests. Biochemical identification was confirmed by PCR amplification of *H. pylori 16S rRNA* and *UreC*. Strains identified as *H. pylori*, were stored in skim milk containing 15% glycerol (Merck), and 10% fetal calf serum (Gibson) at −70°C.

Histological examination of the biopsies, has been performed after H&E, and Giemsa staining; *H pylori* density, gastritis, and inflammation were graded according to the modified Sydney system to mild (MIC), moderate (MAC) and severe active chronic (SAC) gastritis, as previously described ^\[[@B25],[@B26]\]^ .

Chromosomal DNA was extracted from 72-hour-old confluent cells by using the previously described procedure ^\[[@B26]\]^ . PCR primers and protocol for amplification of *16S rRNA*, *cagA* genes as well as *vacA (s1, s2, m1,* and *m2)* alleles, were those previously described ^\[[@B27]\]^ .

DNA preparation and PFGE was performed using the protocol adopted from the previously described procedure, with some modifications ^\[[@B16],[@B20],[@B28],[@B29]\]^ . In brief, two days bacterial cultures were harvested and suspended in one ml phosphate buffer saline, resuspended in 1--2 ml TE buffer to obtain a turbidity equivalent to that of McFarland no. 8. Cell suspension was warmed to 37° C, and 150 μl was mixed with an equal volume of 2% low-melting point (LMP) agarose to prepare the agarose plugs. The solidified plugs were incubated for 48 h in the lysis buffer (0.25M EDTA \[pH 8.0\], 0.5% lauryl sarcosine, 50 μl proteinase K) at 50 °C. The plugs were washed three times in 10 mM TE buffer containing 1 mM phenyl methyl sulfonyl fluoride for 20 min, followed by three times washing in TE buffer each at 4 °C. For the subsequent enzyme reaction, the TE buffer was removed; the plugs were incubated with 100 μl of the XbaI enzyme buffer for 15 min at 36 °C. The enzyme buffer was replaced with 100 μl fresh enzyme solution containing 15 U of enzyme and incubated at 36° C for 4 h. After the incubation period, the plugs were washed once in TE buffer and were loaded into the 1% pulsed field certified agarose gel (Invitrogen). For PFGE analysis, a Field Inversion Gel Electrophoresis (FIGE) system was used for 16 h at 4 °C and 130 V. The pulse times varied from 2.4 to 3 s to examine various-sized fragments. DNA obtained from *Staphylococcus aureus* NCTC 8325 strain was used as the size marker ^\[[@B30]\]^ . Agarose gels were stained with ethidium bromide and photo-graphed.

Findings
========

Forty four pediatric patients with no more than one *H. pylori* strain regarding *vacA* genotypes were used in this study. Information related to the age, sex, the date of *H. pylori* isolation, as well as the *vacA* genotype/*cagA* status is provided in [Table 1](#T1){ref-type="table"}.

###### 

Patients and strains-related data

  **Strain n**   **Group**   **Age**   **Sex**   **vacA**   **cagA status genotype**
  -------------- ----------- --------- --------- ---------- --------------------------
  1              I           09        boy       s1m2       negative
  2              I           12        girl      s1m1       negative
  3              I           06        boy       s1m2       positive
  4              I           10        girl      s1m2       positive
  5              I           13        boy       s1m1       positive
  6              I           04        girl      s2m2       negative
  7              I           11        girl      s1m2       positive
  8              I           05        girl      s2m1       positive
  9              II          14        boy       s2m1       negative
  10             II          09        boy       s1m1       positive
  11             II          07        boy       s2m2       positive
  12             II          11        girl      s1m2       negative
  13             II          10        girl      s2m2       positive
  14             III         12        boy       s1m1       positive
  15             III         10        girl      s2m2       positive
  16             III         13        Boy       s2m1       negative
  17             III         11        girl      s1m2       positive
  18             III         05        boy       s2m2       negative
  19             III         11        boy       s1m2       positive
  20             III         05        boy       s1m2       positive
  21             III         11        boy       s2m1       positive
  22             III         11        boy       s1m2       positive
  23             III         10        girl      s2m1       negative
  24             III         11        girl      s1m2       positive
  25             III         07        girl      s2m1       positive
  26             III         07        boy       s1m1       negative
  27             IV          15        boy       s1m2       positive
  28             IV          11        boy       s2m1       positive
  29             IV          06        girl      s2m2       negative
  30             IV          7.5       girl      s1m1       positive
  31             IV          09        girl      s1m1       negative
  32             IV          11        boy       s2m1       positive
  33             IV          09        girl      s1m2       negative
  34             IV          05        Boy       s1m1       negative
  35             IV          8.5       boy       s2m2       positive
  36             IV          13        Boy       s1m1       positive
  37             IV          15        boy       s2m2       positive
  38             IV          08        girl      s1m2       negative
  39             IV          10        boy       s1m1       positive
  40             IV          06        girl      s2m1       negative
  41             IV          08        boy       s1m2       positive
  42             IV          10        boy       s1m1       positive
  43             IV          09        girl      s1m2       positive
  44             IV          07        girl      s1m2       positive

Group I, II, III and IV corresponded to the strains isolated during 1997--1999, 2001--2003, 2005--2007, and 2007--2009, respectively

The 26695 standard *H. pylori* strain produced 9 reproducible fragments on Xba1 PFGE gels, whereas 35 (80%) of the isolates showed 8 to 12 fragments, 4 isolates contained 5 to 7 fragments and 5 isolates showed 13--14 fragments. The strains were classified according to the numbers and the size of XbaI fragments on PFGE gels. Their comparison showed a marked genomic diversity. Association between the PFGE patterns of the strains and their *cagA* status, as well as *vacA* (*s*,*m*) alleles was evaluated. Relationship between the PFGE pattern of the strains and sex, age and pathological status of children was also assessed. No significant relationship was observed between the patterns of PFGE (number and size of the fragments) and the *cagA* status or *vacA*/*cagA* genotype ([Fig 1](#F1a){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). Also, no significant relationship was observed between age, sex, and pathological status of the children and the PFGE patterns of their isolates. The PFGE patterns of the strains were also compared on the basis of isolation date ([Fig. 2](#F2a){ref-type="fig"}). To confirm the results of visual analysis, the patterns of PFGE were also analyzed using Total Lab software (Total Lab and Phoenix software, [www.totallabs.com](http:\\www.totallabs.com) ). The same conclusion was obtained concerning absence of significant relationship between the PFGE patterns of the isolates and their *vacA*/*cagA* genotype/status, and pathological status of the children. [Fig 3](#F3){ref-type="fig"} represents the relationship between PFGE patterns and *vacA*/*cagA*, as well as the pathological status among 12 isolates of group III (Total Lab and Phoenix software).

![PFGE Profile comparing the *cagA*-positive with *cagA*-negative isolates\
Numbers above of the fig represent the number of strains according to [Table 1](#T1){ref-type="table"}. Lanes 1, 2, 4--8, 10, 12--13, and 15--16 represent the *cagA*-negative isolates. Lanes 3, 9, 11, 14, and 17 represent the cagA-positive isolates. Lane 18: 26695 standard strain (sizes of XbaI digested fragments: 370, 270, 260, 215, 200, 100, 80, and \<80 Kb.](ijp-24-703f1a){#F1a}

![PFGE profile of isolates from group IV\
Numbers above figures represent the number of strains according to [Table 1](#T1){ref-type="table"}. Lane 1: Size marker *Staphylococcus aureus* NCTC 8325 strain.](ijp-24-703f2a){#F2a}

![Representative dendrogram for demonstrating relationship between PFGE patterns and *vacA*/*cagA* and pathological status among 12 isolates of group III performed by Total Lab and Phoenix software. Numbers in left represent the number of strains according to the Table](ijp-24-703f3){#F3}

###### 

Relationship between comparable shared fragments (bands) on PFGE gels and *vacA*/*cagA* genotype/status of the Strains

  **Genotype/Status**   **Number (%) of strains**   **Shared fragment(s) on PFGE gels**
  --------------------- --------------------------- -------------------------------------
  **cagA−**             16 (36)                     no visible shared band
  **cagA+**             28 (64)                     no visible shared band
  **s2m2/cagA−**        3 (7)                       no shared band
  **s1m2/cagA−**        5 (11)                      no shared band
  **s2m1/cagA−**        4 (9)                       no shared band
  **s1m1/cagA−**        4 (9)                       one shared band (200 kb)
  **s2m2/cagA+**        5 (11)                      one shared band (130 kb)
  **s1m2/cagA+**        11 (25)                     one shared band (175 kb)
  **s2m1/cagA+**        5 (11)                      no shared band
  **s1m1/cagA+**        7 (16)                      two shared bands (340, 200 kb)

Comparison of the PFGE patterns between the isolates of group I (1997--99), II (2001--2003), III (2005--2007), and IV showed the considerable genomic changes over time.

Discussion
==========

Selection of unrelated children, favors comparison of genomic DNA among non-clonally related strains. To compare the patterns of PFGE among strains, several investigators have used *Not*I ^\[[@B19],[@B31]--[@B32]\]^ . We found that *Xba* I restriction-endonuclease produced higher (5--14) number of fragments compared to *NotI* (4--8) which allowed a better comparison of various DNA fragments among strains. Comparison of PFGE patterns showed a marked genomic diversity among the strains ([Fig. 1](#F1b){ref-type="fig"}). This is in agreement with data reporting that diversity is more frequent in countries in which *H. pylori* infection is highly prevalent ^\[[@B33]\]^ . Most of the current information about genetic diversity of *H. pylori* has been obtained from genetic analysis of the sequence data obtained from *H. pylori* strains isolated in diverse geographical regions. In the present study, 44 *H. pylori* isolates from 44 different non-related individuals, were characterized in order to define the *H. pylori* population structure. It is a first work performed in this region demonstrating genetic diversity among *H. pylori* isolates from non-related patients.

![PFGE Profile comparing the *cagA*-positive isolates.\
Numbers above of the fig represent the number of the strains according to [Table 1](#T1){ref-type="table"}. Lane 8: size marker *Staphylococcus aureus* NCTC 8325 strain (sizes of fragments: 674, 361, 324, 262, 257, 208, 175, 135, 80, and \<80 Kb, respectively).](ijp-24-703f1b){#F1b}

Comparison of the PFGE patterns suggested that genomic diversity of the strains was not related to the genotype of *vacA*, status of *cagA* and the status of gastric inflammation in children ([Fig. 1](#F1a){ref-type="fig"}--[2](#F2b){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). The fact that identical PFGE pattern did not occur in the strains with similar pathogenicity-associated markers such as *cagA* and *vacA* may suggest that the DNA fragments undergoing genetic changes did not encode proteins that are involved in virulence*.* Comparison of multiple *H. pylori* strains by different methods have shown that *H. pylori* genome has highly plastic gene content and nearly half of the strain-specific genes may be located in each region ^\[[@B34]\]^ .

![PFGE profile of isolates of group III.\
Numbers above figures represent the number of strains according to [Table 1](#T1){ref-type="table"}.](ijp-24-703f2b){#F2b}

Among our isolates, more relationship was observed between the strains isolated in the close period (1997--2009, 2001--2003, 2005--2007, and 2007--2009) and more difference was observed among those obtained in the distant periods (1997 and 2009) regardless of their *cagA*/*vacA* status/genotype. This may be due to adaptation of *H. pylori* strains to variable living conditions during transmission between various host individuals over time. Comparison of 44 unrelated strains suggested that the degree of genetic diversity occurred in this region is very high but this diversity is not related to virulence determinants of the strains, sex, age and pathological status of the children. As these genomic changes may be related to adaptation of *H. pylori* strains to variable living conditions during transmission between various hosts, it may also increase during time in the regions with the high rate of infection such as Iran.

Conclusion
==========

H. pylori strains isolated from children in Iran are extremely diverse and this diversity is not related to vacA /cagA genotype/status of the strains, as well as to sex, age and pathological status of the child patients. As more relationship existed between the strains isolated in the close period, this diversity may be related to adaptation of H. pylori strains to variable living conditions in various host, during time.
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